A Free Service Provided By



Legal Topics

Arbitration and Mediation
Car Accidents
Child Support
Child Custody & Visitation

Copyright Law
Criminal Law
Dangerous Drugs
DUI Drunk Driving

Elderly Laws
Employees' Rights
Estate Planning
Family Law
Immigration Law

Lemon Law
Medical Malpractice
Megan's Law
Mesothelioma & Asbestos

Probate & Estates
Product Recalls
Real Estate

Statute of Limitations

Taxes & the IRS
Traffic Violations
Workers' Compensation
Work Related Injury

Privacy Policy

Contact Us

About Us

Facts - Books - News    U.S. Facts Of Law:

What Is Bextra

Bexta is an anti-inflammatory drug in a class of drugs known as non-steroidal anti-inflammatory drugs (NSAID's).  Bextra reduces inflammation, fever and pain by reducing substances in the body that cause these symptoms.

Bextra was used to treat painful menstruation, osteoarthritis, inflammation and adult rheumatoid arthritis.  Also known as Valdecoxib, the Bextra brand name was manufactured and distributed by Pfizer.

Bextra was removed from the market in 2005 at the request of the FDA due to concerns that it was related to cardiovascular problems including stroke and heart attack.


Bextra Best Sellers from

(no title)


Newsfeed display by CaRP

Bextra News
GN News

This RSS Feed URL Is Deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at

V.ATE: Final Subject Enrolled In Phase 2b Trial Of ATB346 Data Expected In Ma...
Zacks Small Cap Research press release V.ATE: Final Subject Enrolled in Phase 2b Trial of ATB 346 Data Expected in March 2018 Zacks Small Cap Research press release Selective COX 2 inhibitors, such as rofecoxib Vioxx, celecoxib Celebrex, and valdecoxib Bextra, were initially very popular with both physicians and patients for their ability to relieve pain with a significantly decreased risk of adverse GI

Insurers Sue Pfizer To Avoid Covering 400M Settlement Law360 Law360
Insurers Sue Pfizer To Avoid Covering 400M Settlement Law360 Law360 Three insurers hit Pfizer Inc. with a suit on Wednesday seeking to dodge coverage for a 400 million settlement the pharmaceutical giant reached over off label drug marketing claims, telling a New York federal court several exclusions allow them to bar and more raquo

In Unusual Move, Judge Grants CrossFitaposs Request To Unmask Anonymous Peer ...
Science Magazine In unusual move, judge grants CrossFit39s request to unmask anonymous peer reviewers Science Magazine In one notable 2007 case, pharma giant Pfizer subpoenaed NEJM for information about peer reviewers as part of a class action lawsuit related to the marketing of its painkillers Bextra and Celebrex. In an affidavit submitted on behalf of NEJM , Donald

Pfizer Reaches Initial Deal Settling Celebrex, Bextra Suits Bloomberg
Bloomberg Pfizer Reaches Initial Deal Settling Celebrex, Bextra Suits Bloomberg Pfizer Inc. is settling a securities class action lawsuit accusing it of keeping investors in the dark about the cardiovascular risks of the arthritis drugs Celebrex and Bextra, avoiding what could have been a drawn out trial in the 12 year old case

IMPORTANT NOTICE: This webpage is Copyrighted content.  No portion of this page may be copied to any other webpage, forum, blog or other domain page or offline publication without written permission from Violators will be prosecuted to the fullest extent of the law.

The information provided by does not constitute legal advice or any other type of advice and is provided for educational purposes only without warranty of any kind. has not reviewed the information on this page for accuracy and is not responsible for any errors, omissions or inaccuracies.  For legal advice you should consult a licensed attorney.


Copyright All Rights Reserved -
No Portion of This Page May Be Copied Without Written Permission

Facts of Law explaining what is bextra

Facts of Law - What Is Bextra